BIOXCEL THERAPEUTICS INC (BTAI)
US09075P1057 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 40.39M | 65.22M | 193.70M | 233.00M | 213.10M | |||
| Receivables | 3.00K | 71.00K | 200.00K | N/A | N/A | |||
| Inventories | 1.52M | 1.99M | 2.00M | N/A | N/A | |||
| Other Current Assets | 5.88M | 4.86M | 6.90M | 3.90M | 3.90M | |||
| Total Current Assets | 47.79M | 72.14M | 202.90M | 236.80M | 217.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.01M | 1.47M | 2.10M | 2.50M | 2.80M | |||
| Other Non-Current Assets | 87.00K | 87.00K | 900.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 1.10M | 1.56M | 3.00M | 2.60M | 2.80M | |||
| TOTAL ASSETS | 48.89M | 73.70M | 205.90M | 239.40M | 219.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 10.49M | 13.39M | 22.10M | 11.50M | 7.00M | |||
| Accounts Payable | 14.89M | 13.65M | 10.20M | 4.70M | 4.00M | |||
| Other Current Liabilities | 178.00K | 223.00K | 600.00K | 500.00K | 900.00K | |||
| Total Current Liabilities | 25.56M | 27.27M | 32.90M | 16.70M | 11.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 104.44M | 100.60M | 93.10M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.53M | 2.35M | 3.10M | 1.10M | 1.40M | |||
| Total Non-Current Liabilities | 108.97M | 102.94M | 96.20M | 1.10M | 1.40M | |||
| TOTAL LIABILITIES | 134.53M | 130.21M | 129.10M | 17.80M | 13.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -639.34M | -590.60M | -411.50M | -245.80M | -138.90M | |||
| Additional Paid In Capital | 553.66M | 534.06M | 488.30M | 467.40M | 345.50M | |||
| Common Shares | 42.00K | 30.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 42.46M | 29.93M | 28.10M | 28.00M | 24.40M | |||
| Tangible Book Value per Share | -2.02 | -1.89 | 2.73 | 7.92 | 8.47 | |||
| Total Shareholders' Equity | -85.63M | -56.51M | 76.80M | 221.70M | 206.70M | |||
| TOTAL LIABILITIES AND EQUITY | 48.89M | 73.70M | 205.90M | 239.40M | 219.90M | |||
| Statistics | ||||||||
| Debt/Equity | -1.22 | -1.78 | 1.21 | N/A | N/A | |||
| Current Ratio | 1.87 | 2.65 | 6.17 | 14.18 | 18.40 | |||
| Return On Assets (ROA) | -145.21% | -242.94% | -80.51% | -44.67% | -37.37% | |||
| Return On Equity (ROE) | N/A | N/A | -215.83% | -48.23% | -39.75% | |||
All data in USD , ROIC based on taxRate of 0.21